Rheumatoid arthritis: open trials in Poland

20 open trials have a site in Poland. Registry data; only the trial team decides who can take part.

2023-508661-33-00
A clinical study to assess if a new investigational medicinal product called JJP-1212 is safe, tolerable and able to induce a specific immune response in humans
Trial Treatment · Phase 1 · Jjp Biologics Sp. z o.o.
MTZ Clinical Research powered by Pratia, Warsaw
Registry updated 2026-10-30
2026-526538-15-00
A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous CT-P13 in Patients with Moderately to Severely Active Rheumatoid Arthritis
Trial Treatment · Phase 3 · Celltrion Inc.
Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy, Bydgoszcz · NZOZ Lecznica MAK MED S C, Nadarzyn · Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A., Olsztyn · Innova Clinic Sp. z o.o., Plonsk · Samodzielny Publiczny Zespol Opieki Zdrowotnej W Tomaszowie Lubelskim, Tomaszów Lubelski · Medicover Integrated Clinical Services Sp. z o.o., Warsaw · Rheuma Medicus Sp z o o, Warsaw · Klinika Reuma Park Sp. z o.o. S.K., Warsaw · Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o, Wroclaw · ZDROWIE OSTEO-MEDIC S.C. L. i A. Racewicz, A. i J. Supronik
Registry updated 2026-10-30
NCT07412704
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Biokinetica S.A., Jozefow
Registry updated 2026-10-23
NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Trial Treatment · Phase 2 · Hoffmann-La Roche
Nzoz Bif-Med, Bytom · Centrum Kliniczno-Badawcze J. Brzezicki, B. Górnikiewicz-Brzezicka Lekarze Spó?ka Partne, Elbl?g · Malopolskie Badania Kliniczne, Krakow · Zespol Poradni Specjalistycznych REUMED, Lublin · Twoja Przychodnia NCM, Nowa Sól · Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. Eleonory Reicher, Warsaw · Centrum Medyczne Reuma Park, Warsaw · Reumatop Spolka Jawna, Wroclaw
Registry updated 2026-10-16
NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · Hoffmann-La Roche
BIF-MED, Bytom · Centrum Kliniczno-Badawcze J.Brzezicki B.Gornikiewicz-Brzezicka Lekarze sp.p., Elblag · Reumed Sp. z o.o., Lublin · Twoja Przychodnia Nowosolskie Centrum Medyczne Sp. z o.o., Nowa Sol · Klinika Reuma Park Sp. z o.o. S.K., Warsaw · Reumatop Grzegorz Rozumek Karin Pistorius Sp. j., Wroclaw
Registry updated 2026-10-16
NCT07873931
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Bristol-Myers Squibb
Bydgoszcz · Krakow · Poznan
Registry updated 2026-10-14
NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · AstraZeneca
Krakow · Torun · Warsaw · Wroclaw
Registry updated 2026-10-09
NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Trial Treatment · Phase 2 · AbbVie
Medicover Integrated Clinical Services Sp. z o.o., Bydgoszcz · Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy, Bydgoszcz · Malopolskie Centrum Kliniczne, Cracow · Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o., Cracow · Centrum Kliniczno-Badawcze J.Brzezicki B.Gornikiewicz-Brzezicka Lekarze sp.p., Elblag · Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A., Olsztyn · Klinika Reuma Park Sp. z o.o. S.K., Warsaw
Registry updated 2026-10-08
2025-522076-85-00
A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.
Trial Treatment · Phase 2 · AstraZeneca AB
Pratia S.A., Cracow · Malopolskie Badania Kliniczne Sp. z o.o., Cracow · Medicover Integrated Clinical Services Sp. z o.o., Torun · Medicover Integrated Clinical Services Sp. z o.o., Warsaw · Reum-Medica s.c. Bozena Kowalewska, Marek Zawadzki, Wroclaw
Registry updated 2026-10-07
NCT07207954
Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
Trial Treatment · Phase 1 · Lifordi Immunotherapeutics, Inc.
MICS Centrum Medyczne Torun - MICS - PPDS, Torun · Centrum Medyczne Reuma Park, Warsaw
Registry updated 2026-09-29
2025-524005-32-00
A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)
Trial Treatment · Phase 2 · Elevara Medicines Limited
Nova Reuma Domyslawska I Rusilowicz Lekarza Reumatologa I Fizjoterapeuty sp.p., Bialystok · Malopolskie Badania Kliniczne Sp. z o.o., Cracow · Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, Cracow · Provita Sp z o o, Katowice · Santa Familia PTG Łódź, Łódź · Reumed Sp. z o.o., Lublin · Medicome Sp. z o.o., Oswiecim · Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan · Medyczne Centrum Hetmańska Piotr Leszczyński, Poznan · Twoja Przychodnia PCM, Poznan · centrum medyczne Medens s.C. Grupowa praktyka lekarska, Sosnowiec · Rheuma Medicus Sp z o o, Warsaw · Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw
Registry updated 2026-09-21
2025-521034-28-00
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
Trial Treatment · Phase 2 · F. Hoffmann-La Roche AG
BIF-MED, Bytom · Centrum Kliniczno-Badawcze J.Brzezicki B.Gornikiewicz-Brzezicka Lekarze sp.p., Elblag · Reumed Sp. z o.o., Lublin · Twoja Przychodnia Nowosolskie Centrum Medyczne Sp. z o.o., Nowa Sol · Klinika Reuma Park Sp. z o.o. S.K., Warsaw · Reumatop Grzegorz Rozumek Karin Pistorius Sp. j., Wroclaw
Registry updated 2026-09-14
2025-523409-13-00
A study to find how safe different doses of LFD-200 are and how it works in both healthy people and people with moderate to severe rheumatoid arthritis
Trial Treatment · Phase 1 · Lifordi Immunotherapeutics Inc.
Medicover Integrated Clinical Services Sp. z o.o., Torun · Klinika Reuma Park Sp. z o.o. S.K., Warsaw
Registry updated 2026-08-28
NCT07769619
Integrative AI-Based Multiomic and Neurophysiological Profiling of Chronic Pain in Rheumatoid Arthritis
Research · 4th Military Clinical Hospital with Polyclinic, Poland
4th Military Clinical Hospital with Polyclinic (4WSzKzP SPZOZ), Wroclaw
Registry updated 2026-08-18
2025-525113-22-00
A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of NBIM-1008 in Patients with Rheumatoid Arthritis
Trial Treatment · Phase 1 · Neurocrine Biosciences Inc.
Biokinetica S.A., Jozefow
Registry updated 2026-08-10
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy, Bydgoszcz · Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Lodz · Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher, Warsaw
Registry updated 2026-07-31
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Szpital Specjalistyczny Nr I W Bytomiu SPZOZ, Bytom · Uniwersyteckie Centrum Kliniczne, Gdansk · Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Gliwice · Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Lodz
Registry updated 2026-07-14
NCT07371468
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Trial Treatment · Phase 1 · GlaxoSmithKline
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, Cracow · Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan · Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher, Warsaw
Registry updated 2026-06-23
2024-519114-31-00
A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)
Trial Treatment · Phase 1 · Cullinan Therapeutics Inc.
Malopolskie Centrum Kliniczne, Cracow · Biokinetica S.A., Jozefow · Med Polonia Sp z o.o., Poznan · Medicover Integrated Clinical Services Sp. z o.o., Warsaw · Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher, Warsaw
Registry updated 2026-05-06
NCT06671054
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
Trial Treatment · Phase 2 · SynAct Pharma Aps
M2Mmed, Chorzów · Vita Longa Sp. Z o.o., Katowice · Medyczne Centrum Hetmańska, Poznan · DC-MED Michal Kowalski S.K., Swidnica
Registry updated 2025-10-06

All Rheumatoid arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error